99 related articles for article (PubMed ID: 34655510)
1. Blood DNA methylation score predicts breast cancer risk: applying OPERA in molecular, environmental, genetic and analytic epidemiology.
Hopper JL; Nguyen TL; Li S
Mol Oncol; 2022 Jan; 16(1):8-10. PubMed ID: 34655510
[TBL] [Abstract][Full Text] [Related]
2. Blood DNA methylation profiles improve breast cancer prediction.
Kresovich JK; Xu Z; O'Brien KM; Shi M; Weinberg CR; Sandler DP; Taylor JA
Mol Oncol; 2022 Jan; 16(1):42-53. PubMed ID: 34411412
[TBL] [Abstract][Full Text] [Related]
3. Novel mammogram-based measures improve breast cancer risk prediction beyond an established mammographic density measure.
Nguyen TL; Schmidt DF; Makalic E; Maskarinec G; Li S; Dite GS; Aung YK; Evans CF; Trinh HN; Baglietto L; Stone J; Song YM; Sung J; MacInnis RJ; Dugué PA; Dowty JG; Jenkins MA; Milne RL; Southey MC; Giles GG; Hopper JL
Int J Cancer; 2021 May; 148(9):2193-2202. PubMed ID: 33197272
[TBL] [Abstract][Full Text] [Related]
4. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk.
Nguyen TL; Aung YK; Evans CF; Dite GS; Stone J; MacInnis RJ; Dowty JG; Bickerstaffe A; Aujard K; Rommens JM; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Apicella C; Hopper JL
Int J Epidemiol; 2017 Apr; 46(2):652-661. PubMed ID: 28338721
[TBL] [Abstract][Full Text] [Related]
5. Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms.
Nguyen TL; Aung YK; Evans CF; Yoon-Ho C; Jenkins MA; Sung J; Hopper JL; Song YM
Breast Cancer Res; 2015 Nov; 17():142. PubMed ID: 26581435
[TBL] [Abstract][Full Text] [Related]
6. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
[TBL] [Abstract][Full Text] [Related]
7. Going Beyond Conventional Mammographic Density to Discover Novel Mammogram-Based Predictors of Breast Cancer Risk.
Hopper JL; Nguyen TL; Schmidt DF; Makalic E; Song YM; Sung J; Dite GS; Dowty JG; Li S
J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32110975
[TBL] [Abstract][Full Text] [Related]
8. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
[TBL] [Abstract][Full Text] [Related]
9. Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study.
Krishnan K; Baglietto L; Apicella C; Stone J; Southey MC; English DR; Giles GG; Hopper JL
Breast Cancer Res; 2016 Jun; 18(1):63. PubMed ID: 27316945
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Risk Associations with Digital Mammographic Density by Pixel Brightness Threshold and Mammographic System.
Nguyen TL; Choi YH; Aung YK; Evans CF; Trinh NH; Li S; Dite GS; Kim MS; Brennan PC; Jenkins MA; Sung J; Song YM; Hopper JL
Radiology; 2018 Feb; 286(2):433-442. PubMed ID: 29040039
[TBL] [Abstract][Full Text] [Related]
11. Association of contralateral breast cancer risk with mammographic density defined at higher-than-conventional intensity thresholds.
Watt GP; Knight JA; Nguyen TL; Reiner AS; Malone KE; John EM; Lynch CF; Brooks JD; Woods M; Liang X; Bernstein L; Pike MC; Hopper JL; Bernstein JL
Int J Cancer; 2022 Oct; 151(8):1304-1309. PubMed ID: 35315524
[TBL] [Abstract][Full Text] [Related]
12. Familial Aspects of Mammographic Density Measures Associated with Breast Cancer Risk.
Nguyen TL; Li S; Dowty JG; Dite GS; Ye Z; Nguyen-Dumont T; Trinh HN; Evans CF; Tan M; Sung J; Jenkins MA; Giles GG; Southey MC; Hopper JL
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326633
[No Abstract] [Full Text] [Related]
13. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
17. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
[TBL] [Abstract][Full Text] [Related]
18. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
19. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
[TBL] [Abstract][Full Text] [Related]
20. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
